1
/
of
1
Elabscience
SKU:PKSV030409
Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active)
Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active)
Regular price
$290.00 USD
Regular price
Sale price
$290.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active), a cutting-edge product designed to address the urgent need for reliable tools in the fight against the ongoing global pandemic. This meticulously engineered recombinant protein offers a highly active and functional solution for research and diagnostic applications pertaining to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active) showcases an innovative V483A mutation, which enhances its binding affinity to the angiotensin-converting enzyme 2 (ACE2) receptor, a crucial interaction for viral entry into host cells. This modification empowers researchers and scientists with an advanced tool to investigate the intricate mechanisms underlying viral infectivity and host-pathogen interactions.
Furthermore, this recombinant protein is equipped with a strategically incorporated His Tag, facilitating efficient purification and subsequent downstream applications. The His Tag enables streamlined isolation and purification processes, ensuring high yields of pure and active protein, thereby expediting research endeavors and enhancing experimental reproducibility.
The Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active) is meticulously manufactured using state-of-the-art techniques, guaranteeing exceptional quality and reliability. Rigorous quality control measures are implemented throughout the production process to ensure the utmost purity, activity, and consistency of each batch. This commitment to excellence ensures that researchers can confidently rely on this product for their critical investigations.
This versatile recombinant protein finds utility in a wide array of applications, including but not limited to vaccine development, drug discovery, serological assays, and structural biology studies. Its active nature enables accurate and precise evaluation of neutralizing antibodies, facilitating the development of effective therapeutic interventions and vaccines against SARS-CoV-2.
In summary, the Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active) stands as a paramount tool in the battle against the ongoing pandemic. Its exceptional binding affinity, coupled with the convenience of the His Tag, empowers researchers with a reliable and efficient means to unravel the complexities of SARS-CoV-2 infection. With its unwavering commitment to quality and versatility, this product is poised to revolutionize research efforts and contribute significantly to the global fight against COVID-19.
Crafted with utmost precision, the Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active) showcases an innovative V483A mutation, which enhances its binding affinity to the angiotensin-converting enzyme 2 (ACE2) receptor, a crucial interaction for viral entry into host cells. This modification empowers researchers and scientists with an advanced tool to investigate the intricate mechanisms underlying viral infectivity and host-pathogen interactions.
Furthermore, this recombinant protein is equipped with a strategically incorporated His Tag, facilitating efficient purification and subsequent downstream applications. The His Tag enables streamlined isolation and purification processes, ensuring high yields of pure and active protein, thereby expediting research endeavors and enhancing experimental reproducibility.
The Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active) is meticulously manufactured using state-of-the-art techniques, guaranteeing exceptional quality and reliability. Rigorous quality control measures are implemented throughout the production process to ensure the utmost purity, activity, and consistency of each batch. This commitment to excellence ensures that researchers can confidently rely on this product for their critical investigations.
This versatile recombinant protein finds utility in a wide array of applications, including but not limited to vaccine development, drug discovery, serological assays, and structural biology studies. Its active nature enables accurate and precise evaluation of neutralizing antibodies, facilitating the development of effective therapeutic interventions and vaccines against SARS-CoV-2.
In summary, the Recombinant SARS-CoV-2 Spike RBD (V483A)(His Tag)(Active) stands as a paramount tool in the battle against the ongoing pandemic. Its exceptional binding affinity, coupled with the convenience of the His Tag, empowers researchers with a reliable and efficient means to unravel the complexities of SARS-CoV-2 infection. With its unwavering commitment to quality and versatility, this product is poised to revolutionize research efforts and contribute significantly to the global fight against COVID-19.
Share
